126 related articles for article (PubMed ID: 35437860)
1. Biotinylated peptides substituted with D-amino acids with high stability as anti-anaphylactic agents targeting platelet-activating factor.
Sato A; Fukase T; Ebina K
J Pept Sci; 2022 Oct; 28(10):e3412. PubMed ID: 35437860
[TBL] [Abstract][Full Text] [Related]
2. Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors.
Sato A; Yokoyama I; Ebina K
Eur J Pharmacol; 2015 Oct; 764():202-207. PubMed ID: 26142829
[TBL] [Abstract][Full Text] [Related]
3. A biotinylated peptide, BP21, as a novel potent anti-anaphylactic agent targeting platelet-activating factor.
Sato A; Ebina K
J Pept Sci; 2017 Sep; 23(9):727-735. PubMed ID: 28627122
[TBL] [Abstract][Full Text] [Related]
4. An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
Sato A; Suzuki T; Oikawa K; Ohta R; Ebina K
Eur J Pharmacol; 2013 Aug; 714(1-3):142-7. PubMed ID: 23792041
[TBL] [Abstract][Full Text] [Related]
5. A biotinylated peptide, BP21, alleviates hypotension in anaphylactic mice.
Sato A; Ebina K
J Pept Sci; 2019 Aug; 25(8):e3197. PubMed ID: 31264321
[TBL] [Abstract][Full Text] [Related]
6. Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor.
Sato A; Kumagai T; Aoki J; Ebina K
Eur J Pharmacol; 2012 Jun; 685(1-3):205-12. PubMed ID: 22542654
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats.
Sato A; Yokoyama I; Ebina K
Peptides; 2015 Nov; 73():60-6. PubMed ID: 26348270
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for hypothermia during anaphylactic hypotension in awake rats.
Shibamoto T; Ono M; Tanida M; Kuda Y; Kurata Y
Am J Physiol Regul Integr Comp Physiol; 2023 Nov; 325(5):R446-R455. PubMed ID: 37602385
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
10. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
[TBL] [Abstract][Full Text] [Related]
11. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Doebber TW; Wu MS; Biftu T
J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
[TBL] [Abstract][Full Text] [Related]
13. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis.
Jezek J; El Ridi R; Salah M; Wagih A; Aziz HW; Tallima H; El Shafie MH; Khalek TA; Ammou FF; Strongylis C; Moussis V; Tsikaris V
Biopolymers; 2008; 90(3):349-57. PubMed ID: 17549696
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock.
Kang NI; Yoon HY; Kim HA; Kim KJ; Han MK; Lee YR; Hwang PH; Soh BY; Shin SJ; Im SY; Lee HK
J Immunol; 2011 Jun; 186(11):6625-32. PubMed ID: 21531890
[TBL] [Abstract][Full Text] [Related]
15. The primary structure of human liver manganese superoxide dismutase.
Barra D; Schinina ME; Simmaco M; Bannister JV; Bannister WH; Rotilio G; Bossa F
J Biol Chem; 1984 Oct; 259(20):12595-601. PubMed ID: 6386798
[TBL] [Abstract][Full Text] [Related]
16. Highly stable, fluorescence-labeled heptapeptides substituted with a D-amino acid for the specific detection of oxidized low-density lipoprotein in plasma.
Sato A; Yamanaka H; Oe K; Yokoyama I; Yamazaki Y; Ebina K
Chem Biol Drug Des; 2015 Mar; 85(3):348-55. PubMed ID: 25066364
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
Arimura A; Harada M
Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]